Angeles Martin-Requero

Title: Angeles Martin-Requero: Innovator in Neurological Treatments

Introduction: Angeles Martin-Requero, based in Madrid, Spain, is a noteworthy inventor recognized for her contributions to the field of neurological treatments. With a focus on innovative therapeutic solutions, she has developed novel compounds that hold promise for treating various neurological diseases.

Latest Patents: Angeles Martin-Requero holds a notable patent for "CDC-7-inhibitor compounds and use thereof for the treatment of neurological conditions." This invention involves a series of substituted purine derivatives that are capable of inhibiting CDC7 kinase activity. These compounds are particularly relevant for addressing neurological diseases such as Alzheimer's disease, amyotrophic lateral sclerosis, and frontotemporal dementia, which are associated with the hyperphosphorylation of TDP-43 and the resultant aggregate formation induced by CDC7.

Career Highlights: Angeles is affiliated with the Consejo Superior de Investigaciones Científicas (CSIC), where she actively contributes to research and innovation in the field of biomedicine. Her work has garnered attention for its potential impact on therapeutic strategies for debilitating neurological conditions.

Collaborations: Throughout her career, Angeles has collaborated with talented colleagues, including Ana Martinez Gil and Daniel I Perez. These partnerships have undoubtedly enriched her research and contributed to the development of new therapeutic approaches.

Conclusion: Angeles Martin-Requero exemplifies the spirit of innovation in the realm of neurological research. Her patent for CDC-7-inhibitor compounds signifies a critical step toward effective treatments for various neurological diseases, illustrating her dedication to improving patient outcomes through scientific advancements.